SlideShare ist ein Scribd-Unternehmen logo
1 von 6
FIBRINOLYTICS
(Thrombolytics)
S. Parasuraman, M.Pharm., Ph.D.,
Associate Professor,
Faculty of Pharmacy, AIMST University
Thrombolytics
‱ These are drugs used to lyse thrombi/clot to
recanalize occluded blood vessels (mainly coronary
artery). They are therapeutic rather than prophylactic
and work by activating the natural fibrinolytic system.
Thrombolytics
Streptokinase, Urokinase, Alteplase (rt-PA), Reteplase
Tenecteplase:
‱ Streptokinase is a protein synthesized by Streptococci that
combines with the proactivator plasminogen.
‱ Urokinase is a human enzyme synthesized by the kidney
that directly converts plasminogen to active plasmin.
‱ Alteplase is recombinant tissue plasminogen activator (rt-
PA). Risk of bleeding (0.5–5%) is the most important
concern.
‱ Reteplase is produced by recombinant technology and less
selective for fibrin bound plasminogen.
‱ Tenecteplase is a genetically engineered substitution mutant
of native t-plasminogen activator has higher fibrin selectivity.
Thrombolytics
Streptokinase, Urokinase, Alteplase (rt-PA), Reteplase
Tenecteplase:
‱ Uses of fibrinolytics:
‱ Acute myocardial infarction: The chief indication for
fibrinolytic therapy is ST-Elevation Myocardial
Infarction (STEMI).
‱ Deep vein thrombosis (DVT) in leg, pelvis, shoulder
etc.; up to 60% patients of DVT can be successfully
treated by fibrinolytics.
‱ Pulmonary embolism (PE) Fibrinolytic therapy is
indicated in large, life-threatening PE.
Thrombolytics
Streptokinase, Urokinase, Alteplase (rt-PA), Reteplase
Tenecteplase:
‱ Uses of fibrinolytics:
‱ Stroke: Thrombolytic therapy of ischaemic stroke is
dependent on time-lapse since symptom onset;
earlier, the better.
‱ Peripheral arterial occlusion: Indicated only when
surgical thrombectomy is not possible
Thrombolytics
‱ Administration of fibrinolytic drugs by the i.v. route is
indicated in cases of pulmonary embolism with
hemodynamic instability, severe deep venous
thrombosis such as the superior vena caval syndrome,
and ascending thrombophlebitis of the iliofemoral vein
with severe lower extremity edema.
‱ These drugs are also given intra-arterially, especially for
peripheral vascular disease.
Thank you

Weitere Àhnliche Inhalte

Was ist angesagt?

thiazides
 thiazides  thiazides
thiazides
Islam Home
 

Was ist angesagt? (20)

Calcium channel blockers nikku
Calcium channel blockers nikkuCalcium channel blockers nikku
Calcium channel blockers nikku
 
Anticoagulants
AnticoagulantsAnticoagulants
Anticoagulants
 
Heparin
HeparinHeparin
Heparin
 
Antiplatelet drugs
Antiplatelet drugsAntiplatelet drugs
Antiplatelet drugs
 
Antiplatelet Drugs
Antiplatelet DrugsAntiplatelet Drugs
Antiplatelet Drugs
 
Heparin
HeparinHeparin
Heparin
 
Digoxin & Nitroglycerin by Dr. Sanaullah Aslam (Complete)
Digoxin & Nitroglycerin by Dr. Sanaullah Aslam (Complete)Digoxin & Nitroglycerin by Dr. Sanaullah Aslam (Complete)
Digoxin & Nitroglycerin by Dr. Sanaullah Aslam (Complete)
 
Ace inhibitor
Ace inhibitorAce inhibitor
Ace inhibitor
 
Anticoagulants sa
Anticoagulants saAnticoagulants sa
Anticoagulants sa
 
Fibrinolytics & antifibrinolytics
Fibrinolytics & antifibrinolyticsFibrinolytics & antifibrinolytics
Fibrinolytics & antifibrinolytics
 
Fibrinolytics & antiplatelets
Fibrinolytics & antiplateletsFibrinolytics & antiplatelets
Fibrinolytics & antiplatelets
 
Antiplatelet drugs
Antiplatelet drugsAntiplatelet drugs
Antiplatelet drugs
 
Plasma expanders.pptx
Plasma expanders.pptxPlasma expanders.pptx
Plasma expanders.pptx
 
Presentation of alteplase drugs
Presentation of alteplase drugsPresentation of alteplase drugs
Presentation of alteplase drugs
 
Vasodilators
VasodilatorsVasodilators
Vasodilators
 
Heparin
HeparinHeparin
Heparin
 
thiazides
 thiazides  thiazides
thiazides
 
Antiarrhythmic drugs bds
Antiarrhythmic drugs bdsAntiarrhythmic drugs bds
Antiarrhythmic drugs bds
 
ANTICOAGULANTS
ANTICOAGULANTSANTICOAGULANTS
ANTICOAGULANTS
 
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
Diuretics-Mechanism of action,Diuretic Types and Adverse effects,Drug specifi...
 

Ähnlich wie Thrombolytics.pptx

Anti-hormonal and other anticancer agents agents.pptx
Anti-hormonal and other anticancer agents agents.pptxAnti-hormonal and other anticancer agents agents.pptx
Anti-hormonal and other anticancer agents agents.pptx
MuhammadShaheer398150
 
THROMBOLYTIC DRUGS.ppt
THROMBOLYTIC DRUGS.pptTHROMBOLYTIC DRUGS.ppt
THROMBOLYTIC DRUGS.ppt
anesthesia2023
 
fibrinolyticsyaqub-151219124320 chhangr.pptx
fibrinolyticsyaqub-151219124320 chhangr.pptxfibrinolyticsyaqub-151219124320 chhangr.pptx
fibrinolyticsyaqub-151219124320 chhangr.pptx
CutiePie71
 

Ähnlich wie Thrombolytics.pptx (20)

fibrinolytics.pptx
fibrinolytics.pptxfibrinolytics.pptx
fibrinolytics.pptx
 
Alteplase
AlteplaseAlteplase
Alteplase
 
Thrombolytics
ThrombolyticsThrombolytics
Thrombolytics
 
Thrombolytics ppt
Thrombolytics pptThrombolytics ppt
Thrombolytics ppt
 
PARENTERAL anticoagulants, fibrinolytics
PARENTERAL anticoagulants, fibrinolyticsPARENTERAL anticoagulants, fibrinolytics
PARENTERAL anticoagulants, fibrinolytics
 
Tissue Plasminogen Activator.pptx
Tissue Plasminogen Activator.pptxTissue Plasminogen Activator.pptx
Tissue Plasminogen Activator.pptx
 
Fibrinolytics drugs.
Fibrinolytics drugs.Fibrinolytics drugs.
Fibrinolytics drugs.
 
Fibrinolytics and antifibrinolytics
Fibrinolytics and antifibrinolyticsFibrinolytics and antifibrinolytics
Fibrinolytics and antifibrinolytics
 
Fibrinolytics and antifibrinolytics
Fibrinolytics and antifibrinolyticsFibrinolytics and antifibrinolytics
Fibrinolytics and antifibrinolytics
 
Fibrinolytics,antifibrinolytics,antiplatelet drugs
Fibrinolytics,antifibrinolytics,antiplatelet drugsFibrinolytics,antifibrinolytics,antiplatelet drugs
Fibrinolytics,antifibrinolytics,antiplatelet drugs
 
Cardioversion.pptx
Cardioversion.pptxCardioversion.pptx
Cardioversion.pptx
 
Cardioversion.pptx
Cardioversion.pptxCardioversion.pptx
Cardioversion.pptx
 
FIBRINOLYTICS AND ANTIFIBRINOLYTICS DRUGS
FIBRINOLYTICS AND ANTIFIBRINOLYTICS DRUGSFIBRINOLYTICS AND ANTIFIBRINOLYTICS DRUGS
FIBRINOLYTICS AND ANTIFIBRINOLYTICS DRUGS
 
9-Thrombolytics Drugs.pptx
9-Thrombolytics Drugs.pptx9-Thrombolytics Drugs.pptx
9-Thrombolytics Drugs.pptx
 
Anti-hormonal and other anticancer agents agents.pptx
Anti-hormonal and other anticancer agents agents.pptxAnti-hormonal and other anticancer agents agents.pptx
Anti-hormonal and other anticancer agents agents.pptx
 
Fibrinolytics
FibrinolyticsFibrinolytics
Fibrinolytics
 
THROMBOLYTIC DRUGS.ppt
THROMBOLYTIC DRUGS.pptTHROMBOLYTIC DRUGS.ppt
THROMBOLYTIC DRUGS.ppt
 
fibrinolyticsyaqub-151219124320 chhangr.pptx
fibrinolyticsyaqub-151219124320 chhangr.pptxfibrinolyticsyaqub-151219124320 chhangr.pptx
fibrinolyticsyaqub-151219124320 chhangr.pptx
 
Development of hybridoma kk
Development of hybridoma kkDevelopment of hybridoma kk
Development of hybridoma kk
 
Thrombolytic agent
Thrombolytic agentThrombolytic agent
Thrombolytic agent
 

Mehr von Subramani Parasuraman

Mehr von Subramani Parasuraman (20)

Role of preclinical studies in drug discovery
Role of preclinical studies in drug discoveryRole of preclinical studies in drug discovery
Role of preclinical studies in drug discovery
 
Tolerance, autoimmunity and autoimmune diseases.pptx
Tolerance, autoimmunity and autoimmune diseases.pptxTolerance, autoimmunity and autoimmune diseases.pptx
Tolerance, autoimmunity and autoimmune diseases.pptx
 
Introduction to pharmacology (For Allied health students)
Introduction to pharmacology (For Allied health students)Introduction to pharmacology (For Allied health students)
Introduction to pharmacology (For Allied health students)
 
Pharmacodynamics - Introduction (Allied health students)
Pharmacodynamics - Introduction (Allied health students)Pharmacodynamics - Introduction (Allied health students)
Pharmacodynamics - Introduction (Allied health students)
 
Sustainability in preclinical drug discovery.pptx
Sustainability in preclinical drug discovery.pptxSustainability in preclinical drug discovery.pptx
Sustainability in preclinical drug discovery.pptx
 
Role of preclinical studies in drug discovery.pptx
Role of preclinical studies in drug discovery.pptxRole of preclinical studies in drug discovery.pptx
Role of preclinical studies in drug discovery.pptx
 
Research with animals and animal models.pptx
Research with animals and animal models.pptxResearch with animals and animal models.pptx
Research with animals and animal models.pptx
 
Nicotine and Tobacco
Nicotine and TobaccoNicotine and Tobacco
Nicotine and Tobacco
 
Statistical software.pptx
Statistical software.pptxStatistical software.pptx
Statistical software.pptx
 
Cerebellum and control of postures and movements.pptx
Cerebellum and control of postures and movements.pptxCerebellum and control of postures and movements.pptx
Cerebellum and control of postures and movements.pptx
 
Drugs Used in Renal Alteration
Drugs Used in Renal AlterationDrugs Used in Renal Alteration
Drugs Used in Renal Alteration
 
Drugs Used in Endocrine Alteration
Drugs Used in Endocrine AlterationDrugs Used in Endocrine Alteration
Drugs Used in Endocrine Alteration
 
Antidiabetic drugs
Antidiabetic drugsAntidiabetic drugs
Antidiabetic drugs
 
Pancreatic Hormones
Pancreatic HormonesPancreatic Hormones
Pancreatic Hormones
 
Terrestrial laboratory animals
Terrestrial laboratory animalsTerrestrial laboratory animals
Terrestrial laboratory animals
 
Drugs used in haematological disorders
Drugs used in haematological disordersDrugs used in haematological disorders
Drugs used in haematological disorders
 
Laboratory animals
Laboratory animalsLaboratory animals
Laboratory animals
 
Immunomodulators-1.pptx
Immunomodulators-1.pptxImmunomodulators-1.pptx
Immunomodulators-1.pptx
 
Immunomodulators - 3.pptx
Immunomodulators - 3.pptxImmunomodulators - 3.pptx
Immunomodulators - 3.pptx
 
Immunomodulators - 2.pptx
Immunomodulators - 2.pptxImmunomodulators - 2.pptx
Immunomodulators - 2.pptx
 

KĂŒrzlich hochgeladen

Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
KarakKing
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
ssuserdda66b
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
QucHHunhnh
 

KĂŒrzlich hochgeladen (20)

Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Sociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning ExhibitSociology 101 Demonstration of Learning Exhibit
Sociology 101 Demonstration of Learning Exhibit
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...Making communications land - Are they received and understood as intended? we...
Making communications land - Are they received and understood as intended? we...
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptxHMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
HMCS Max Bernays Pre-Deployment Brief (May 2024).pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
TỔNG ÔN TáșŹP THI VÀO LỚP 10 MÔN TIáșŸNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGở Â...
TỔNG ÔN TáșŹP THI VÀO LỚP 10 MÔN TIáșŸNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGở Â...TỔNG ÔN TáșŹP THI VÀO LỚP 10 MÔN TIáșŸNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGở Â...
TỔNG ÔN TáșŹP THI VÀO LỚP 10 MÔN TIáșŸNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGở Â...
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
How to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POSHow to Manage Global Discount in Odoo 17 POS
How to Manage Global Discount in Odoo 17 POS
 

Thrombolytics.pptx

  • 1. FIBRINOLYTICS (Thrombolytics) S. Parasuraman, M.Pharm., Ph.D., Associate Professor, Faculty of Pharmacy, AIMST University
  • 2. Thrombolytics ‱ These are drugs used to lyse thrombi/clot to recanalize occluded blood vessels (mainly coronary artery). They are therapeutic rather than prophylactic and work by activating the natural fibrinolytic system.
  • 3. Thrombolytics Streptokinase, Urokinase, Alteplase (rt-PA), Reteplase Tenecteplase: ‱ Streptokinase is a protein synthesized by Streptococci that combines with the proactivator plasminogen. ‱ Urokinase is a human enzyme synthesized by the kidney that directly converts plasminogen to active plasmin. ‱ Alteplase is recombinant tissue plasminogen activator (rt- PA). Risk of bleeding (0.5–5%) is the most important concern. ‱ Reteplase is produced by recombinant technology and less selective for fibrin bound plasminogen. ‱ Tenecteplase is a genetically engineered substitution mutant of native t-plasminogen activator has higher fibrin selectivity.
  • 4. Thrombolytics Streptokinase, Urokinase, Alteplase (rt-PA), Reteplase Tenecteplase: ‱ Uses of fibrinolytics: ‱ Acute myocardial infarction: The chief indication for fibrinolytic therapy is ST-Elevation Myocardial Infarction (STEMI). ‱ Deep vein thrombosis (DVT) in leg, pelvis, shoulder etc.; up to 60% patients of DVT can be successfully treated by fibrinolytics. ‱ Pulmonary embolism (PE) Fibrinolytic therapy is indicated in large, life-threatening PE.
  • 5. Thrombolytics Streptokinase, Urokinase, Alteplase (rt-PA), Reteplase Tenecteplase: ‱ Uses of fibrinolytics: ‱ Stroke: Thrombolytic therapy of ischaemic stroke is dependent on time-lapse since symptom onset; earlier, the better. ‱ Peripheral arterial occlusion: Indicated only when surgical thrombectomy is not possible
  • 6. Thrombolytics ‱ Administration of fibrinolytic drugs by the i.v. route is indicated in cases of pulmonary embolism with hemodynamic instability, severe deep venous thrombosis such as the superior vena caval syndrome, and ascending thrombophlebitis of the iliofemoral vein with severe lower extremity edema. ‱ These drugs are also given intra-arterially, especially for peripheral vascular disease. Thank you